Dr. Larry Goldenberg is awarded the Queen's 2012 Diamond Jubilee Medal

Date Posted: 
2012-03-16

Dr. Larry Goldenberg, Professor and Head, Department of Urologic Sciences at Vancouver General Hospital and UBC and Director of Development at the Vancouver Prostate Centre, will be awarded the Queen's 2012 Diamond Jubilee Medal on April 11th, 2012. The Medal honours significant contributions and achievements made by Canadians.

Dr. Goldenberg has contributed significantly to championing research by raising funds to create the infrastructure for the Prostate Centre, which has become a leading National Centre for Excellence in prostate research, education and healthcare delivery.   He has also long been a champion of technology, and was the driving force behind the acquisition of a state-of-the-art da Vinci Robot at VGH which is used in many types of minimally invasive surgery including kidney transplant.

In addition, Dr. Goldenberg is the Director of Men's Health Initiative of BC, a large-scale initiative aimed at improving men's health and quality of life through leadership, awareness and education campaigns, research, and disseminating best practices in clinical care.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Movember Foundation 2018

Movember 2018

The Movember Foundation's fundraiser runs from November 1 to 30.  Click here to donate to The Vancouver Prostate Centre team as we join teams across Canada to raise funds for men's health research in the areas of prostate cancer, testicular cancer, mental health and suicide prevention.

Employment

Work at the Vancouver Prostate Centre

Tuesday, November 27, 2018

An innovative new study advances personalized medicine for prostate cancer patients

Drs Chi and Wyatt
Tuesday, October 23, 2018

Three researchers receive Prostate Cancer Canada & Movember Foundation grants for biomarker development